Tajikistan: COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility
The project responds to the government's request for ADB support under APVAX to help meet COVID-19 vaccine response challenges. In accordance with the guidance of the APVAX policy, the project investment component under APVAX will support ADB's procurement and project implementation, which will benefit Tajikistan given due diligence assessments that identified fiduciary-related risks.
Concepcion, Rhodora B.
Central and West Asia Department
Request for information
|Project Name||COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility|
|Country / Economy||Tajikistan
|Project Type / Modality of Assistance||Grant
|Source of Funding / Amount||
|Strategic Agendas||Inclusive economic growth
|Drivers of Change||Gender Equity and Mainstreaming
|Sector / Subsector||
Health / Disease control of communicable disease
|Gender Equity and Mainstreaming||Effective gender mainstreaming|
|Description||The project responds to the government's request for ADB support under APVAX to help meet COVID-19 vaccine response challenges. In accordance with the guidance of the APVAX policy, the project investment component under APVAX will support ADB's procurement and project implementation, which will benefit Tajikistan given due diligence assessments that identified fiduciary-related risks.|
|Project Rationale and Linkage to Country/Regional Strategy||COVID-19 rapidly accelerated into a global pandemic, as declared by the World Health Organization (WHO) on 11 March 2020. The number of cases grew exponentially across countries and continents, resulting in closed borders; travel restrictions; lockdowns; national health crises; and disruptions in trade, investment, tourism, and remittance flows. Tajikistan confirmed its first 15 cases of COVID-19 on 30 April 2020 and, by 28 February 2021, that number had risen to 13,308. Tajikistan also confirmed 90 deaths. Only 407,841 tests were completed in Tajikistan up to 28 February 2021, indicating a high probability of undetected cases. The country is ill-equipped to handle large-scale health crises and remains highly vulnerable to the COVID-19 pandemic. Limited testing capacity and absence of strict social distancing and self-isolation measures have led to increasing pressures in the health system.|
Vulnerable groups protected from morbidity and mortality caused by COVID-19
The spread of the SARS-CoV-2 virus reduced and confidence of citizens restored
|Description of Outcome||Priority populations vaccinated against COVID-19|
|Progress Toward Outcome|
|Description of Project Outputs||
COVID-19 vaccines procured and delivered to designated delivery points
Vaccine program implementation capacity strengthened
|Status of Implementation Progress (Outputs, Activities, and Issues)|
|Summary of Environmental and Social Aspects|
|Stakeholder Communication, Participation, and Consultation|
|During Project Design|
|During Project Implementation|
|Responsible ADB Officer||Concepcion, Rhodora B.|
|Responsible ADB Department||Central and West Asia Department|
|Responsible ADB Division||Tajikistan Resident Mission|
Ministry of Health and Social Protection of the Population of the Republic of Tajikistan
|Fact Finding||11 Mar 2021 to 12 Apr 2021|
|MRM||30 Mar 2021|
|Approval||16 Jun 2021|
|Last Review Mission||-|
|Last PDS Update||16 Jun 2021|
|Approval||Signing Date||Effectivity Date||Closing|
|16 Jun 2021||21 Jun 2021||12 Jul 2021||31 Dec 2023||-||-|
|Financing Plan||Grant Utilization|
|Total (Amount in US$ million)||Date||ADB||Others||Net Percentage|
|Project Cost||26.80||Cumulative Contract Awards|
|ADB||25.00||17 Jun 2022||24.17||0.00||97%|
|Cofinancing||0.00||17 Jun 2022||24.02||0.00||96%|
|Status of Covenants|
Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.
The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.
The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.
In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.
Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.
None currently available.
Evaluation Documents See also: Independent Evaluation
None currently available.
None currently available.
The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.
Requests for information may also be directed to the InfoUnit.
Helping Tajikistan Vaccinate against COVID-19ADB has approved a $25 million grant to help the Government of Tajikistan procure and deploy COVID-19 vaccines and strengthen the country’s capacity to implement its vaccination program.
$25 Million ADB Grant to Procure COVID-19 Vaccines for TajikistanThe Asian Development Bank has approved a $25 million grant to help the Government of Tajikistan procure and deploy coronavirus disease (COVID-19) vaccines and strengthen the country’s capacity to implement its vaccination program.
No tenders for this project were found.
No contracts awarded for this project were found
|Title||Document Type||Document Date|
|COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility: Procurement Plan||Procurement Plans||Jun 2021|